Provided by Tiger Fintech (Singapore) Pte. Ltd.

Electrocore LLC

4.95
-0.1300-2.56%
Post-market: 4.950.00000.00%16:10 EST
Volume:29.33K
Turnover:145.57K
Market Cap:39.58M
PE:-3.07
High:5.10
Open:5.01
Low:4.88
Close:5.08
52wk High:19.49
52wk Low:4.16
Shares:8.00M
Float Shares:5.61M
Volume Ratio:1.00
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6138
EPS(LYR):-1.5884
ROE:-210.58%
ROA:-44.19%
PB:35.56
PE(LYR):-3.12

Loading ...

Company Profile

Company Name:
Electrocore LLC
Exchange:
NASDAQ
Establishment Date:
2005
Employees:
73
Office Location:
200 Forge Way,Suite 205,Rockaway,New Jersey,United States
Zip Code:
07866
Fax:
973 290 9171
Introduction:
electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.

Directors

Name
Position
Daniel S. Goldberger
Chief Executive Officer and Director
Thomas J. Errico
Director and Chairman
Elena Bonfiglioli
Director
John P. Gandolfo
Director
Julie A. Goldstein
Director
Patricia Wilber
Director
Thomas M. Patton
Director

Shareholders

Name
Position
Daniel S. Goldberger
Chief Executive Officer and Director
Joshua S. Lev
Chief Financial Officer